To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MLF2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
499 supporting clones for gene MLF2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB472958.
matches multiple genes
hippocampus .a 1 to 458 1 to 458   tiling clone, also hits gene speezeeby 458/458
(100 %)
1 diff
(99.8 %id)
BQ058546 lymph, lymphoma, cell line .a 174 to 951 1 to 794   tiling clone,   794/926
(85 %)
59 diff
(93.7 %id)
AK289869 caudate nucleus .b 1 to 854 1 to 854 M35I tiling clone,   854/854
(100 %)
1 diff
(99.9 %id)
DC326410 caudate nucleus .b 1 to 551 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
NM_005439.2   .b 1 to 1391 1 to 1391 exact RefSeq,   1391/1391
(100 %)
0 diff
(100 %id)
CN283238 embryonic stem cells, cell lines H1, H7, andH9 .c 1 to 385 387 to 3   tiling clone, Submitted on the opposite strand 385/387
(99 %)
0 diff
(100 %id)
AK313998 subthalamic nucleus .c 135 to 1244 1 to 1111 exact tiling clone,   1111/1111
(100 %)
1 diff
(100.0 %id)
BE834217 ovary .c 469 to 578 23 to 130       109/131
(83 %)
10 diff
(92.4 %id)
CD620484   .c 489 to 1060 576 to 5       572/576
(99 %)
1 diff
(99.9 %id)
CB112654 Liver .c 556 to 1012 1 to 457       457/457
(100 %)
0 diff
(100 %id)
EC473587 Prostate .c 693 to 768 86 to 11       76/86
(88 %)
0 diff
(100 %id)
CU452273 epidermis .c 767 to 1121 17 to 371       355/387
(91 %)
7 diff
(98.2 %id)
AI207862 schizophrenic brain S-11 frontal lobe .c 843 to 1241 1 to 399     Submitted on the opposite strand 399/399
(100 %)
5 diff
(98.8 %id)
AA984731 schizophrenic brain S-11 frontal lobe .c 844 to 1241 1 to 398     Submitted on the opposite strand 398/398
(100 %)
3 diff
(99.3 %id)
BM690469 eye, RPE and Choroid .c 1160 to 1755 1 to 596   tiling clone, fully sequenced,   596/596
(100 %)
3 diff
(99.5 %id)
TI_154110018   .c 1229 to 2035 841 to 42   tiling clone, AAA   800/955
(83 %)
15 diff
(98.5 %id)
AA480835 ovarian tumor, ovary .c 1318 to 1742 1 to 424   fully sequenced,   424/424
(100 %)
3 diff
(99.3 %id)
AA457726 ovarian tumor, ovary .c 1712 to 2045 334 to 1   tiling clone, fully sequenced,   334/334
(100 %)
1 diff
(99.8 %id)
BM663285 eye, RPE and Choroid .c 1725 to 2045 338 to 18   fully sequenced, AAA   321/321
(100 %)
3 diff
(99.1 %id)
AL570368 placenta, Placenta Cot 25-normalized .d 1 to 855 1 to 861   tiling clone,   861/927
(92 %)
33 diff
(96.5 %id)
AL570346 placenta, Placenta Cot 25-normalized .d 917 to 1674 768 to 5   tiling clone,   764/922
(82 %)
0 diff
(100 %id)
BQ337337 marrow .d 962 to 1101 10 to 152   tiling clone,   143/154
(92 %)
8 diff
(94.9 %id)
AV657309 corresponding non cancerous liver tissue .d 984 to 1395 1 to 412     Submitted on the opposite strand 412/412
(100 %)
6 diff
(98.6 %id)
AV657327 corresponding non cancerous liver tissue .d 984 to 1395 1 to 412     Submitted on the opposite strand 412/412
(100 %)
5 diff
(98.8 %id)
AV657544 corresponding non cancerous liver tissue .d 984 to 1618 1 to 637   tiling clone, Submitted on the opposite strand 637/637
(100 %)
12 diff
(98.2 %id)
BQ320525 colon .d 1073 to 1434 1 to 359   tiling clone,   359/359
(100 %)
6 diff
(98.4 %id)
BG286326 bladder, transitional cell papilloma, cell line .d 1244 to 1716 1 to 474   AAA   474/474
(100 %)
5 diff
(99.0 %id)
BI850830 bladder, transitional cell papilloma, cell line .d 1244 to 1716 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
AU122833   .d 1245 to 1715 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
CD369650 Alveolar Macrophage, lung .d 1246 to 1716 489 to 19   AAA   471/471
(100 %)
0 diff
(100 %id)
AW026401 brain, glioblastoma (pooled) .d 1248 to 1716 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AI090190 uterus .d 1252 to 1722 471 to 1       471/471
(100 %)
0 diff
(100 %id)
DB542593 hippocampus .d 1269 to 1723 1 to 455     Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AI583191 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1269 to 1725 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AV690073 hepatocellular carcinoma .d 1292 to 1723 1 to 432   AAA   432/432
(100 %)
0 diff
(100 %id)
AI626110 colon .d 1324 to 1716 393 to 1       393/393
(100 %)
0 diff
(100 %id)
CD556523 brain, Pituitary .d 1329 to 1723 1 to 395   AAA   395/395
(100 %)
0 diff
(100 %id)
TI_151770833   .d 1353 to 1734 113 to 494   tiling clone,   382/1059
(36 %)
1 diff
(100.0 %id)
AI696159 thymus, pooled .d 1355 to 1728 374 to 1       374/374
(100 %)
2 diff
(99.5 %id)
AJ710334 heart .d 1359 to 1716 1 to 358   AAA   358/358
(100 %)
0 diff
(100 %id)
BP390185 pancreatic islet .d 1407 to 1718 1 to 312     Submitted on the opposite strand 312/312
(100 %)
0 diff
(100 %id)
BF115261 fibrotheoma, ovary .d 1407 to 1725 319 to 1       319/319
(100 %)
0 diff
(100 %id)
BE857523 brain, glioblastoma (pooled) .d 1408 to 1716 309 to 1       309/309
(100 %)
0 diff
(100 %id)
BM740011 Ascites, stomach .d 1419 to 1716 1 to 298   AAA   298/298
(100 %)
0 diff
(100 %id)
AI357711 Kidney, renal cell tumor .d 1421 to 1726 306 to 1       306/306
(100 %)
0 diff
(100 %id)
BE885057 leiomyosarcoma, uterus .d 1466 to 1720 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BE873177 adenocarcinoma, colon .d 1467 to 1712 1 to 246       246/246
(100 %)
0 diff
(100 %id)
AW131297 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1620 to 1726 107 to 1       107/107
(100 %)
0 diff
(100 %id)
TI_44166681   .e 1 to 492 117 to 608   tiling clone,   492/608
(80 %)
6 diff
(99.1 %id)
TI_44000345   .e 45 to 718 92 to 763       672/763
(88 %)
7 diff
(99.1 %id)
NR_026581.1   .e 46 to 1933 1 to 1888 exact RefSeq, tiling clone,   1888/1888
(100 %)
0 diff
(100 %id)
TI_45209185   .e 365 to 1229 82 to 957       874/957
(91 %)
33 diff
(96.6 %id)
TI_45210682   .e 365 to 1132 142 to 915       774/1094
(70 %)
16 diff
(98.6 %id)
BG700778 brain, hippocampus .e 370 to 1126 1 to 755       755/755
(100 %)
6 diff
(99.3 %id)
BI596847 brain, hypothalamus .e 370 to 1141 1 to 778       778/871
(89 %)
14 diff
(98.4 %id)
BI603249 brain, hypothalamus .e 370 to 1132 1 to 769       769/948
(81 %)
17 diff
(98.3 %id)
BM761076 lymph node, stomach .e 375 to 1036 1 to 662       662/662
(100 %)
0 diff
(100 %id)
BM845663 lymph node, stomach .e 375 to 737 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BM856026 stomach .e 375 to 665 1 to 291       291/291
(100 %)
0 diff
(100 %id)
DB481014.
matches multiple genes
hippocampus .e 377 to 851 1 to 475     also hits gene speezeeby 475/475
(100 %)
0 diff
(100 %id)
BM763245 myeloma .e 377 to 967 1 to 591       591/591
(100 %)
0 diff
(100 %id)
TI_44000945   .e 381 to 970 86 to 674       589/674
(87 %)
8 diff
(98.9 %id)
CR590498 Placenta Cot 25-normalized .e 382 to 1918 1 to 1537 exact     1537/1537
(100 %)
0 diff
(100 %id)
BX357280 Placenta Cot 25-normalized .e 382 to 1314 1 to 926   fully sequenced,   926/926
(100 %)
20 diff
(97.9 %id)
TI_43961329   .e 382 to 1164 59 to 855       797/855
(93 %)
30 diff
(96.5 %id)
TI_57235184   .e 382 to 1333 28 to 981       954/1007
(94 %)
41 diff
(96.0 %id)
BG722005 testis .e 384 to 1241 1 to 851       851/863
(98 %)
23 diff
(97.4 %id)
CX871056 embryonic stem .e 384 to 1132 1 to 749       749/749
(100 %)
1 diff
(99.9 %id)
BI116964 lung, small cell carcinoma .e 385 to 1126 1 to 755       755/838
(90 %)
30 diff
(96.5 %id)
BU556949 ovary, teratocarcinoma, cell line .e 386 to 1306 1 to 930       930/930
(100 %)
11 diff
(98.9 %id)
CR613239 Placenta Cot 25-normalized .e 388 to 1898 1 to 1511 exact     1511/1511
(100 %)
0 diff
(100 %id)
BI550273 brain, hippocampus .e 389 to 1320 1 to 940       937/943
(99 %)
39 diff
(95.9 %id)
BI908931 leukocyte .e 391 to 1333 1 to 946       946/972
(97 %)
37 diff
(96.2 %id)
BI914764 brain .e 392 to 1164 1 to 774       774/774
(100 %)
1 diff
(99.9 %id)
TI_57244101   .e 392 to 1164 30 to 803       774/803
(96 %)
7 diff
(99.2 %id)
CR594751 HeLa cells Cot 25-normalized .e 393 to 1885 1 to 1493 exact     1493/1493
(100 %)
0 diff
(100 %id)
CR601889 T cells (Jurkat cell line) Cot10-normalized .e 393 to 1895 1 to 1503 exact     1503/1503
(100 %)
0 diff
(100 %id)
CR622171 adult brain .e 393 to 1888 1 to 1496 exact     1496/1496
(100 %)
0 diff
(100 %id)
AL533278 adult brain, brain .e 393 to 1134 1 to 743   fully sequenced,   743/743
(100 %)
3 diff
(99.6 %id)
CV808852 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 393 to 1169 1 to 778       778/891
(87 %)
11 diff
(98.8 %id)
CR597712 Placenta Cot 25-normalized .e 394 to 1894 1 to 1501 exact     1501/1501
(100 %)
0 diff
(100 %id)
AL552460 placenta, Placenta Cot 25-normalized .e 394 to 1100 1 to 707   fully sequenced,   707/707
(100 %)
2 diff
(99.8 %id)
AA205057   .e 394 to 800 1 to 408       408/408
(100 %)
12 diff
(97.1 %id)
TI_57238238   .e 394 to 1107 33 to 747       715/747
(95 %)
8 diff
(99.0 %id)
TI_44167065   .e 394 to 1241 81 to 940       860/950
(90 %)
28 diff
(97.1 %id)
CR614975 T cells (Jurkat cell line) Cot10-normalized .e 395 to 1890 1 to 1496 exact     1496/1496
(100 %)
0 diff
(100 %id)
AL557551 T cells (Jurkat cell line), T cells from T cell leukemia .e 395 to 1109 1 to 715       715/715
(100 %)
3 diff
(99.6 %id)
AL558933 T cells from T cell leukemia .e 395 to 1100 1 to 706   fully sequenced,   706/706
(100 %)
1 diff
(99.9 %id)
AL556246 placenta .e 395 to 1100 1 to 706   fully sequenced,   706/706
(100 %)
6 diff
(99.2 %id)
DB473821 hippocampus .e 395 to 875 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
BI550281 brain, hippocampus .e 395 to 1334 1 to 953       855/981
(87 %)
41 diff
(95.9 %id)
BI552893 brain, hippocampus .e 395 to 1229 1 to 840       840/840
(100 %)
16 diff
(98.1 %id)
BP346887 brain .e 395 to 976 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG252615 adenocarcinoma, cell line, Liver .e 397 to 1152 1 to 750       750/1108
(67 %)
19 diff
(98.3 %id)
BG333919 melanotic melanoma, skin .e 397 to 1207 1 to 815       815/815
(100 %)
38 diff
(95.4 %id)
BG334118 melanotic melanoma, skin .e 397 to 1168 1 to 768       768/932
(82 %)
19 diff
(98.0 %id)
CF265198 Brain glioblastoma .e 397 to 1245 1 to 856       856/860
(99 %)
16 diff
(98.2 %id)
CT004988 T-Lymphocytes .e 397 to 1185 1 to 790       790/790
(100 %)
2 diff
(99.8 %id)
CT000164 T-Lymphocytes .e 397 to 1157 1 to 762       762/764
(99 %)
2 diff
(99.8 %id)
AI929649 brain, frontal lobe .e 398 to 686 1 to 289   fully sequenced,   289/289
(100 %)
1 diff
(99.7 %id)
BI548154 brain, hippocampus .e 398 to 1168 1 to 778       778/866
(89 %)
15 diff
(98.3 %id)
BQ223462 melanotic melanoma, skin .e 398 to 780 7 to 391       385/1043
(36 %)
15 diff
(98.6 %id)
AL551251 placenta, Placenta Cot 25-normalized .e 401 to 1100 15 to 713   fully sequenced,   699/713
(98 %)
7 diff
(99.1 %id)
DB482434.
matches multiple genes
hippocampus .e 402 to 896 1 to 495     also hits gene speezeeby 495/495
(100 %)
0 diff
(100 %id)
BI857617 breast, mammary adenocarcinoma, cell line .e 402 to 1169 1 to 774       774/850
(91 %)
16 diff
(98.2 %id)
TI_57187862   .e 402 to 1169 52 to 825       774/850
(91 %)
16 diff
(98.2 %id)
TI_59380755   .e 402 to 1056 61 to 718       658/660
(99 %)
10 diff
(98.5 %id)
BM922110 pooled brain, lung, testis .e 403 to 1365 1 to 977 G173X E195X R198A E199G T200D ...     977/1025
(95 %)
21 diff
(98.0 %id)
CD172295 White Matter .e 403 to 1165 1 to 766       766/838
(91 %)
5 diff
(99.5 %id)
BG826363 muscle, rhabdomyosarcoma .e 404 to 1217 1 to 824       824/837
(98 %)
20 diff
(97.7 %id)
CR625356 Placenta Cot 25-normalized .e 405 to 1892 1 to 1488 exact     1488/1488
(100 %)
0 diff
(100 %id)
AL550630 placenta, Placenta Cot 25-normalized .e 405 to 1473 1 to 1059 S216X P239L S240P R241D Q242S ...     1059/1063
(99 %)
20 diff
(98.2 %id)
BX386271 Placenta Cot 25-normalized .e 405 to 1380 1 to 971 Q175R E176R E177S R178G Q179R ...     971/971
(100 %)
14 diff
(98.6 %id)
BM923234 pooled colon, kidney, stomach .e 405 to 1147 1 to 749       749/1180
(63 %)
12 diff
(99.0 %id)
TI_57198231   .e 405 to 1014 92 to 698       607/698
(86 %)
24 diff
(96.6 %id)
TI_57182889   .e 405 to 1125 35 to 759       725/763
(95 %)
12 diff
(98.5 %id)
TI_57237743   .e 405 to 1130 31 to 759       729/759
(96 %)
17 diff
(97.8 %id)
AA121347 brain, neuroepithelial cells .e 406 to 762 1 to 361       362/361
(100 %)
14 diff
(96.2 %id)
BQ430868 melanotic melanoma, skin .e 406 to 1267 1 to 878       878/883
(99 %)
23 diff
(97.4 %id)
BF182638 large cell carcinoma, lung .e 407 to 1162 1 to 756       756/1073
(70 %)
24 diff
(97.8 %id)
BI259155 cervical carcinoma cell line, cervix .e 408 to 1075 1 to 668       668/670
(99 %)
1 diff
(99.9 %id)
CX867892 embryonic stem .e 408 to 1178 1 to 771       771/771
(100 %)
2 diff
(99.8 %id)
TI_44170776   .e 408 to 1261 113 to 956       844/1135
(74 %)
23 diff
(98.0 %id)
BM922970 leukocyte .e 409 to 1439 14 to 1047 D174G Q175P E176G E177G R178A ...     1034/1048
(98 %)
23 diff
(97.9 %id)
CX164694 human embryonic stem cells differentiated toan early endodermal cell type .e 410 to 1226 1 to 817       817/817
(100 %)
3 diff
(99.7 %id)
CX762546 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 410 to 1169 1 to 754     Submitted on the opposite strand 754/757
(99 %)
6 diff
(99.3 %id)
CX753760 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 410 to 1022 29 to 641     Submitted on the opposite strand 613/641
(95 %)
5 diff
(99.3 %id)
BM926582 pooled lung and spleen .e 411 to 1341 19 to 953       935/1120
(83 %)
17 diff
(98.5 %id)
BQ691194 ductal carcinoma, cell line, Pancreas .e 412 to 1162 14 to 767       754/957
(78 %)
12 diff
(98.8 %id)
AF070539 brain .e 413 to 1921 1 to 1508 exact AAA   1508/1508
(100 %)
2 diff
(99.9 %id)
Z43262 brain, total brain .e 413 to 752 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
CR624015 Placenta Cot 25-normalized .e 413 to 1888 1 to 1476 exact     1476/1476
(100 %)
0 diff
(100 %id)
AL553057 placenta, Placenta Cot 25-normalized .e 413 to 1100 1 to 689   fully sequenced,   689/689
(100 %)
13 diff
(98.2 %id)
BG700214 brain, hippocampus .e 413 to 1191 1 to 779       779/784
(99 %)
8 diff
(99.0 %id)
BI915857 brain .e 413 to 1255 1 to 841       841/841
(100 %)
9 diff
(99.0 %id)
BM480225 duodenal adenocarcinoma, cell line, small intestine .e 413 to 1338 1 to 934       934/990
(94 %)
36 diff
(96.4 %id)
CR591577 Placenta Cot 25-normalized .e 414 to 1863 1 to 1450 exact     1450/1450
(100 %)
0 diff
(100 %id)
AL554788 placenta, Placenta Cot 25-normalized .e 414 to 1539 1 to 1109 Q175R E176R E177S R178G Q179R ...     1109/1134
(97 %)
30 diff
(97.4 %id)
BX365425 Placenta Cot 25-normalized .e 414 to 1381 1 to 963 I87L G88W N89I M90H E91G ...     963/965
(99 %)
17 diff
(98.3 %id)
BQ889267 dorsal root ganglia .e 414 to 1321 1 to 922       922/931
(99 %)
19 diff
(98.0 %id)
CX164657 human embryonic stem cells differentiated toan early endodermal cell type .e 414 to 1161 1 to 748       748/748
(100 %)
2 diff
(99.8 %id)
CR594365 Placenta Cot 25-normalized .e 415 to 1899 1 to 1485 exact     1485/1485
(100 %)
0 diff
(100 %id)
AL543440 placenta, Placenta Cot 25-normalized .e 415 to 1100 1 to 686   fully sequenced,   686/686
(100 %)
0 diff
(100 %id)
BI552726 brain, hippocampus .e 415 to 1261 1 to 837       837/1016
(82 %)
22 diff
(97.9 %id)
TI_57244378   .e 415 to 1255 29 to 867       839/867
(96 %)
13 diff
(98.6 %id)
AL515246 neuroblastoma, placenta .e 416 to 1198 1 to 785   fully sequenced,   785/785
(100 %)
0 diff
(100 %id)
CR592962 Placenta Cot 25-normalized .e 416 to 1899 1 to 1484 exact     1484/1484
(100 %)
0 diff
(100 %id)
CR604849 Neuroblastoma Cot 25-normalized .e 416 to 1876 1 to 1461 exact     1461/1461
(100 %)
0 diff
(100 %id)
CR612884 neuroblastoma .e 416 to 1929 1 to 1514 exact     1514/1514
(100 %)
0 diff
(100 %id)
CR616586 Placenta Cot 25-normalized .e 416 to 1891 1 to 1476 exact     1476/1476
(100 %)
0 diff
(100 %id)
AL527230 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 416 to 1100 1 to 684   fully sequenced,   684/684
(100 %)
2 diff
(99.8 %id)
AL549119 placenta, Placenta Cot 25-normalized .e 416 to 1100 1 to 684   fully sequenced,   684/684
(100 %)
1 diff
(99.9 %id)
AL552064 placenta, Placenta Cot 25-normalized .e 416 to 1035 1 to 620   fully sequenced,   620/620
(100 %)
1 diff
(99.9 %id)
BE409250 choriocarcinoma, placenta .e 416 to 1123 1 to 703       703/735
(95 %)
13 diff
(98.3 %id)
BF794885 lymph, lymphoma, cell line .e 416 to 1169 1 to 756       756/797
(94 %)
20 diff
(97.5 %id)
BG253022 adenocarcinoma, cell line, Liver .e 416 to 1171 1 to 751       751/767
(97 %)
23 diff
(97.1 %id)
BQ946151 leiomyosarcoma, uterus .e 416 to 1184 1 to 773       773/918
(84 %)
17 diff
(98.2 %id)
CX751474 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 416 to 1162 1 to 742     Submitted on the opposite strand 742/742
(100 %)
5 diff
(99.4 %id)
BE728086 melanotic melanoma, skin .e 417 to 1241 1 to 815       815/898
(90 %)
25 diff
(97.3 %id)
BX333862 Neuroblastoma Cot 50-normalized .e 418 to 1229 1 to 810       810/810
(100 %)
3 diff
(99.7 %id)
BI760476 pooled colon, kidney, stomach .e 418 to 1258 1 to 845       845/845
(100 %)
6 diff
(99.3 %id)
BM555048 duodenal adenocarcinoma, cell line, small intestine .e 418 to 1381 1 to 979 D115R D174G Q175P E176G E177R ...     979/1059
(92 %)
39 diff
(96.4 %id)
BM927348 lymph, lymphoma, cell line .e 418 to 1340 1 to 929       929/1066
(87 %)
13 diff
(98.8 %id)
BU145830 epidermoid carcinoma, cell line, salivary gland .e 418 to 1267 1 to 855       855/858
(99 %)
11 diff
(98.8 %id)
BQ672201 epidermoid carcinoma, cell line, salivary gland .e 418 to 1327 1 to 922       922/930
(99 %)
13 diff
(98.7 %id)
TI_57147940   .e 418 to 1258 35 to 879       845/879
(96 %)
12 diff
(98.7 %id)
TI_57230175   .e 418 to 1170 87 to 847       761/854
(89 %)
16 diff
(98.2 %id)
BG707000 brain, hypothalamus .e 419 to 1164 1 to 746       746/746
(100 %)
4 diff
(99.5 %id)
BI871465 adenocarcinoma, cell line, Liver .e 419 to 1170 1 to 760       760/853
(89 %)
16 diff
(98.2 %id)
BM801659 duodenal adenocarcinoma, cell line, small intestine .e 419 to 1267 40 to 892       853/954
(89 %)
16 diff
(98.4 %id)
BM924490 pooled colon, kidney, stomach .e 419 to 1267 1 to 863       863/1072
(80 %)
33 diff
(97.0 %id)
BX338110 Placenta Cot 25-normalized .e 420 to 1168 1 to 754       708/926
(76 %)
47 diff
(95.0 %id)
BF969284 adrenal cortex carcinoma, cell line, adrenal gland .e 420 to 1169 1 to 760       760/885
(85 %)
29 diff
(96.8 %id)
BG825370 muscle, rhabdomyosarcoma .e 420 to 1294 1 to 874       874/903
(96 %)
15 diff
(98.4 %id)
BM803996 embryonal carcinoma, cell line, testis .e 420 to 1169 1 to 758       758/967
(78 %)
15 diff
(98.5 %id)
BE797664 lung, small cell carcinoma .e 421 to 1158 28 to 753       726/756
(96 %)
14 diff
(98.2 %id)
BM921132 pooled brain, lung, testis .e 421 to 1321 1 to 915       915/1036
(88 %)
30 diff
(97.2 %id)
TI_57148166   .e 421 to 1229 29 to 842       814/843
(96 %)
14 diff
(98.4 %id)
BQ934610 epidermoid carcinoma, cell line, lung .e 423 to 1372 1 to 954 F203S R204G Q205S Q206S R207V ...     954/965
(98 %)
19 diff
(98.1 %id)
BF311324 brain, neuroblastoma .e 424 to 1178 1 to 746       748/913
(81 %)
23 diff
(97.5 %id)
CX163971 human embryonic stem cells differentiated toan early endodermal cell type .e 424 to 1229 1 to 806       806/806
(100 %)
0 diff
(100 %id)
BM829844 stomach .e 425 to 1108 1 to 684       684/684
(100 %)
0 diff
(100 %id)
BM830161 stomach .e 425 to 1013 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BI760395 pooled colon, kidney, stomach .e 426 to 1229 1 to 809       809/810
(99 %)
8 diff
(99.1 %id)
CA487926   .e 426 to 1267 1 to 852       852/855
(99 %)
14 diff
(98.4 %id)
CR975111 T-Lymphocytes .e 426 to 1168 1 to 744       744/755
(98 %)
7 diff
(99.1 %id)
BI116084 lung, small cell carcinoma .e 427 to 1169 1 to 744       744/745
(99 %)
10 diff
(98.7 %id)
BM478757 melanotic melanoma, skin .e 427 to 1331 13 to 929       917/1113
(82 %)
36 diff
(96.8 %id)
BU170346 eye, retinoblastoma .e 427 to 1168 1 to 746       746/884
(84 %)
8 diff
(99.1 %id)
CD359057 testis .e 427 to 1267 1 to 854       854/887
(96 %)
16 diff
(98.2 %id)
CR598086 neuroblastoma .e 428 to 1903 1 to 1476 exact     1476/1476
(100 %)
0 diff
(100 %id)
CR610405 neuroblastoma .e 428 to 1911 1 to 1484 exact     1484/1484
(100 %)
0 diff
(100 %id)
ES313917 beard hair, skin .e 428 to 874 1 to 448       448/457
(98 %)
8 diff
(98.3 %id)
BG333116 large cell carcinoma, lung .e 428 to 1124 1 to 699       699/699
(100 %)
8 diff
(98.9 %id)
BG820109 anaplastic oligodendroglioma with 1p/19qloss, brain .e 428 to 1196 1 to 769       769/776
(99 %)
2 diff
(99.8 %id)
BU540604 large cell carcinoma, lung .e 428 to 1330 1 to 917       917/938
(97 %)
22 diff
(97.7 %id)
CX166706 human embryonic stem cells differentiated toan early endodermal cell type .e 428 to 1139 1 to 712       712/712
(100 %)
0 diff
(100 %id)
TI_57201436   .e 428 to 1167 38 to 784       747/785
(95 %)
17 diff
(97.9 %id)
TI_59379792   .e 428 to 1169 105 to 849       745/832
(89 %)
16 diff
(98.1 %id)
CN290447 embryonic stem cells, DMSO-treated H9 cellline .e 429 to 1125 1 to 697       697/697
(100 %)
5 diff
(99.3 %id)
AA476514   .e 429 to 1068 1 to 637       635/637
(99 %)
9 diff
(98.6 %id)
BG115938 duodenal adenocarcinoma, cell line, small intestine .e 429 to 1147 9 to 721       713/894
(79 %)
18 diff
(98.0 %id)
BG389959 embryonal carcinoma, cell line, testis .e 429 to 1336 1 to 916       916/927
(98 %)
37 diff
(96.1 %id)
BG425041 Kidney, renal cell adenocarcinoma .e 429 to 1148 1 to 713       713/1033
(69 %)
16 diff
(98.5 %id)
BI762061 pooled colon, kidney, stomach .e 429 to 1168 1 to 744       744/769
(96 %)
17 diff
(97.8 %id)
BM919987 pooled pancreas and spleen .e 429 to 1290 1 to 878       878/960
(91 %)
17 diff
(98.3 %id)
BU170980 eye, retinoblastoma .e 429 to 1200 1 to 772       772/908
(85 %)
11 diff
(98.8 %id)
CX763122 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 429 to 1124 1 to 691     Submitted on the opposite strand 691/814
(84 %)
7 diff
(99.2 %id)
TI_57151353   .e 429 to 1168 32 to 775       744/800
(93 %)
21 diff
(97.4 %id)
TI_59394428   .e 429 to 1192 85 to 852       768/768
(100 %)
7 diff
(99.1 %id)
CR990917 T-Lymphocytes .e 429 to 1232 1 to 803       803/803
(100 %)
3 diff
(99.7 %id)
BM016047 breast, mammary adenocarcinoma, cell line .e 430 to 1192 1 to 767       767/767
(100 %)
7 diff
(99.1 %id)
BQ889734 dorsal root ganglia .e 430 to 1294 1 to 875       875/886
(98 %)
20 diff
(97.8 %id)
BQ673376 epidermoid carcinoma, cell line, salivary gland .e 430 to 1339 1 to 911       911/913
(99 %)
8 diff
(99.2 %id)
BQ953267 eye, normal pigmented retinal epithelium .e 430 to 1302 1 to 882       882/898
(98 %)
11 diff
(98.8 %id)
BQ956753 brain, neuroblastoma, cell line .e 430 to 1251 1 to 834       834/949
(87 %)
25 diff
(97.4 %id)
CN290452 embryonic stem cells, DMSO-treated H9 cellline .e 431 to 1125 1 to 695       695/695
(100 %)
4 diff
(99.5 %id)
BU158440 large cell carcinoma, lung .e 431 to 1328 1 to 912       912/914
(99 %)
22 diff
(97.6 %id)
CX781436 human embryonic stem cells .e 431 to 1212 1 to 782       782/782
(100 %)
2 diff
(99.8 %id)
BG332662 large cell carcinoma, lung .e 432 to 1169 1 to 731       731/928
(78 %)
20 diff
(97.9 %id)
BM477077 lymph, lymphoma, cell line .e 432 to 1379 48 to 1003 E195X L209P E210G F211V R222T ...     956/1168
(81 %)
28 diff
(97.7 %id)
TI_44185193   .e 432 to 1283 27 to 880       854/880
(97 %)
17 diff
(98.1 %id)
BC002340 Lung, small cell carcinoma .e 433 to 1921 1 to 1489 exact available from MGC, AAA   1489/1489
(100 %)
0 diff
(100 %id)
BM762355 myeloma .e 433 to 1085 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BM764152 myeloma .e 433 to 890 1 to 458       458/458
(100 %)
0 diff
(100 %id)
BM847685 myeloma .e 433 to 938 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BM849168 myeloma .e 433 to 1052 1 to 620       620/620
(100 %)
0 diff
(100 %id)
AW247729 lung, small cell carcinoma .e 434 to 794 12 to 372       361/372
(97 %)
8 diff
(97.9 %id)
BG828239 muscle, rhabdomyosarcoma .e 434 to 1320 1 to 888       886/888
(99 %)
38 diff
(95.8 %id)
BQ049890 lymph, lymphoma, cell line .e 434 to 1342 1 to 913       913/1022
(89 %)
12 diff
(98.9 %id)
BQ225328 epithelioid carcinoma, Pancreas .e 434 to 1290 1 to 864       864/864
(100 %)
8 diff
(99.1 %id)
BQ946079 leiomyosarcoma, uterus .e 434 to 1345 1 to 923       923/928
(99 %)
24 diff
(97.5 %id)
CX166507 human embryonic stem cells differentiated toan early endodermal cell type .e 434 to 1169 1 to 736       736/738
(99 %)
2 diff
(99.8 %id)
CX752773 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 434 to 1109 1 to 676     Submitted on the opposite strand 676/676
(100 %)
0 diff
(100 %id)
BG030019 breast, mammary adenocarcinoma, cell line .e 435 to 1169 16 to 754       739/1025
(72 %)
15 diff
(98.6 %id)
BU153748 eye, retinoblastoma .e 435 to 1333 1 to 902       902/902
(100 %)
9 diff
(99.1 %id)
BQ721547 sympathetic trunk .e 435 to 1132 47 to 751       705/967
(72 %)
22 diff
(97.8 %id)
TI_57241626   .e 435 to 1162 9 to 746       738/755
(97 %)
22 diff
(97.1 %id)
TI_57228225   .e 435 to 1090 52 to 717       666/744
(89 %)
15 diff
(98.0 %id)
BG469643 adenocarcinoma cell line, colon .e 436 to 1289 1 to 857       857/859
(99 %)
17 diff
(98.1 %id)
BU501461 eye, normal pigmented retinal epithelium .e 436 to 1215 1 to 783       783/903
(86 %)
9 diff
(99.1 %id)
CV569394 cornea, eye .e 436 to 1048 1 to 613       613/613
(100 %)
0 diff
(100 %id)
CR988392 T-Lymphocytes .e 436 to 1244 1 to 811       811/813
(99 %)
5 diff
(99.4 %id)
BG252283 adenocarcinoma, cell line, Liver .e 437 to 1130 1 to 692       692/755
(91 %)
14 diff
(98.2 %id)
BM803897 leiomyosarcoma, uterus .e 437 to 1378 1 to 948 E195Q R222T R223K A224G E225G ...     948/1004
(94 %)
14 diff
(98.7 %id)
BM449969 melanotic melanoma, skin .e 437 to 1155 1 to 727       727/1208
(60 %)
13 diff
(99.0 %id)
CX783472 human embryonic stem cells .e 437 to 1212 1 to 776       776/776
(100 %)
0 diff
(100 %id)
CX754890 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 437 to 1148 1 to 706     Submitted on the opposite strand 706/745
(94 %)
12 diff
(98.4 %id)
CX761786 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 437 to 1169 1 to 727       727/730
(99 %)
8 diff
(99.0 %id)
CR995818 T-Lymphocytes .e 437 to 1160 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
BE018190 cervical carcinoma cell line, cervix .e 438 to 980 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CX752801 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 438 to 1165 1 to 728     Submitted on the opposite strand 728/729
(99 %)
1 diff
(99.9 %id)
CX761323 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 438 to 1148 1 to 708     Submitted on the opposite strand 708/834
(84 %)
7 diff
(99.2 %id)
CX761272 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 438 to 1169 1 to 726     Submitted on the opposite strand 726/862
(84 %)
11 diff
(98.8 %id)
BE869155 adenocarcinoma, colon .e 439 to 1166 1 to 718       718/718
(100 %)
11 diff
(98.5 %id)
BU153109 large cell carcinoma, lung .e 439 to 1168 1 to 742       742/927
(80 %)
26 diff
(97.2 %id)
BQ890423 brain, neuroblastoma, cell line .e 439 to 1320 1 to 884       884/884
(100 %)
8 diff
(99.1 %id)
BU902628 leiomyosarcoma, uterus .e 439 to 1167 1 to 739       739/945
(78 %)
15 diff
(98.5 %id)
CN290459 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 440 to 1135 1 to 695       695/695
(100 %)
4 diff
(99.5 %id)
CN290462 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 440 to 1122 1 to 682       682/682
(100 %)
4 diff
(99.5 %id)
BE296858 muscle, rhabdomyosarcoma .e 440 to 1004 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BG698680 skin .e 440 to 1258 1 to 823       823/824
(99 %)
18 diff
(97.9 %id)
BM924609 pooled colon, kidney, stomach .e 440 to 1321 1 to 893       893/1037
(86 %)
18 diff
(98.3 %id)
CX761739 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 440 to 1155 1 to 716       716/717
(99 %)
2 diff
(99.8 %id)
CN290454 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 441 to 1169 1 to 730       730/746
(97 %)
3 diff
(99.6 %id)
CN290458 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 441 to 1169 1 to 731       731/736
(99 %)
3 diff
(99.6 %id)
CR617192 Placenta Cot 25-normalized .e 441 to 1897 1 to 1457 exact     1457/1457
(100 %)
0 diff
(100 %id)
AL546130 placenta, Placenta Cot 25-normalized .e 441 to 1135 1 to 695   fully sequenced,   695/695
(100 %)
1 diff
(99.9 %id)
BG328162 adenocarcinoma cell line, colon .e 441 to 1259 1 to 812       812/1055
(76 %)
22 diff
(98.0 %id)
BG329259 eye, retinoblastoma .e 441 to 1150 1 to 706       706/707
(99 %)
15 diff
(97.9 %id)
BG746388 adenocarcinoma cell line, colon .e 441 to 1130 1 to 690       690/690
(100 %)
1 diff
(99.9 %id)
CN290471 embryonic stem cells, DMSO-treated H9 cellline .e 442 to 1125 1 to 686       686/688
(99 %)
3 diff
(99.6 %id)
CR620761 HeLa cells Cot 25-normalized .e 443 to 1888 1 to 1446 exact     1446/1446
(100 %)
0 diff
(100 %id)
AL555971 placenta .e 443 to 1499 1 to 1040 A191R F192L D193M D194T E195S ...     1040/1132
(91 %)
29 diff
(97.5 %id)
BX365631   .e 443 to 1125 1 to 683       683/683
(100 %)
0 diff
(100 %id)
BE735079 choriocarcinoma, placenta .e 443 to 1282 17 to 846       830/987
(84 %)
18 diff
(98.2 %id)
BE734896 choriocarcinoma, placenta .e 443 to 1374 19 to 938 G154W H155A H156S I157H R158P ...     920/1177
(78 %)
50 diff
(95.8 %id)
BG765519 melanotic melanoma, high MDR (cell line), skin .e 443 to 1175 1 to 737       737/854
(86 %)
10 diff
(98.9 %id)
CN290464 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 444 to 1151 1 to 709       709/709
(100 %)
6 diff
(99.2 %id)
BF314268 brain, neuroblastoma .e 444 to 1169 1 to 717       717/956
(75 %)
14 diff
(98.6 %id)
BF689779 melanotic melanoma, high MDR (cell line), skin .e 444 to 1128 1 to 682   fully sequenced,   682/682
(100 %)
8 diff
(98.9 %id)
BI195816 brain, neuroblastoma .e 444 to 1099 1 to 656       656/656
(100 %)
3 diff
(99.6 %id)
AI752155 Bone, Hip .e 444 to 901 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
CN290457 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 445 to 1083 1 to 639       639/639
(100 %)
5 diff
(99.3 %id)
CR624020 adult brain .e 448 to 1885 1 to 1438 exact     1438/1438
(100 %)
0 diff
(100 %id)
AL532950 adult brain, brain .e 448 to 1169 1 to 722   fully sequenced,   722/722
(100 %)
2 diff
(99.8 %id)
BE277847 melanotic melanoma, skin .e 448 to 1124 1 to 676       676/736
(91 %)
10 diff
(98.7 %id)
BE890938 melanotic melanoma, skin .e 448 to 1142 1 to 693       693/728
(95 %)
6 diff
(99.2 %id)
BU855670 ovary, teratocarcinoma, cell line .e 448 to 1362 1 to 921 D174E Q175P E176G E177G R178A ...     921/923
(99 %)
15 diff
(98.4 %id)
TI_57171420   .e 448 to 1007 58 to 616       559/616
(90 %)
6 diff
(99.1 %id)
CR987378 T-Lymphocytes .e 448 to 1275 1 to 831       831/834
(99 %)
9 diff
(99.0 %id)
ES313876 beard hair, skin .e 449 to 962 1 to 513       513/513
(100 %)
6 diff
(98.9 %id)
BE613852 leiomyosarcoma, uterus .e 449 to 1056 1 to 607       607/608
(99 %)
2 diff
(99.7 %id)
TI_154189249   .e 449 to 1374 47 to 965 S201P R202D F203S R204G Q205S ...     919/998
(92 %)
8 diff
(99.2 %id)
BE894644 melanotic melanoma, skin .e 451 to 1168 1 to 710       710/744
(95 %)
14 diff
(98.2 %id)
BF219721 lung, small cell carcinoma .e 452 to 976 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
BE281086 choriocarcinoma, placenta .e 452 to 1168 29 to 745       717/755
(94 %)
15 diff
(98.1 %id)
BE614967 adenocarcinoma, Pancreas .e 452 to 1168 1 to 718       718/1145
(62 %)
10 diff
(99.2 %id)
BF311756 brain, neuroblastoma .e 452 to 1201 1 to 744       744/923
(80 %)
20 diff
(97.9 %id)
BF312156 brain, neuroblastoma .e 452 to 1250 1 to 805       805/921
(87 %)
22 diff
(97.7 %id)
BF313649 brain, neuroblastoma .e 452 to 934 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BI196389 brain, neuroblastoma .e 452 to 1289 1 to 834       834/887
(94 %)
20 diff
(97.8 %id)
BE615076 adenocarcinoma, Pancreas .e 453 to 1169 1 to 719       719/825
(87 %)
10 diff
(98.8 %id)
BU169710 embryonal carcinoma, cell line, testis .e 453 to 1349 1 to 899       899/904
(99 %)
13 diff
(98.6 %id)
BU196862 ductal carcinoma, cell line, Pancreas .e 453 to 1326 1 to 878       878/879
(99 %)
14 diff
(98.5 %id)
CA488718   .e 453 to 1111 1 to 663       663/1008
(65 %)
5 diff
(99.6 %id)
CF126284 Chondrosarcoma Lung Metastasis cell lines, lung .e 453 to 1216 1 to 762       762/762
(100 %)
3 diff
(99.7 %id)
BE792954 lung, small cell carcinoma .e 456 to 1168 1 to 712       712/852
(83 %)
14 diff
(98.4 %id)
BE885412 leiomyosarcoma, uterus .e 457 to 1164 1 to 708       708/874
(81 %)
8 diff
(99.1 %id)
TI_154162545   .e 457 to 1005 76 to 624       549/1318
(41 %)
7 diff
(99.5 %id)
BE076569 breast .e 459 to 820 369 to 7     Submitted on the opposite strand 363/369
(98 %)
10 diff
(97.3 %id)
TI_57150655   .e 459 to 1282 29 to 853       825/854
(96 %)
19 diff
(97.8 %id)
TI_154137701   .e 462 to 1005 52 to 595       544/898
(60 %)
8 diff
(99.2 %id)
BE871193 adenocarcinoma, colon .e 463 to 1171 1 to 708       708/709
(99 %)
6 diff
(99.2 %id)
BI762820 pooled colon, kidney, stomach .e 463 to 1282 1 to 821       821/822
(99 %)
14 diff
(98.3 %id)
BM800358 leiomyosarcoma, uterus .e 466 to 1343 1 to 880       880/1059
(83 %)
12 diff
(98.9 %id)
CX759981 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 467 to 1217 1 to 749     Submitted on the opposite strand 749/749
(100 %)
7 diff
(99.1 %id)
TI_154194526   .e 467 to 1320 49 to 889       841/1023
(82 %)
24 diff
(97.7 %id)
BC000898 Placenta, choriocarcinoma .e 473 to 1921 1 to 1449 exact available from MGC, AAA   1449/1449
(100 %)
0 diff
(100 %id)
BU528376 epidermoid carcinoma, cell line, lung .e 475 to 1335 1 to 871       871/912
(95 %)
15 diff
(98.4 %id)
BF975445 B-cells, primary B-cells from tonsils (cell line) .e 484 to 1169 1 to 685       685/1102
(62 %)
17 diff
(98.5 %id)
BI117775 lung, small cell carcinoma .e 484 to 1195 1 to 711       711/711
(100 %)
5 diff
(99.3 %id)
BM926470 pooled lung and spleen .e 489 to 1577 3 to 1097 P235T E236*     1095/1113
(98 %)
30 diff
(97.4 %id)
BF970584 adrenal cortex carcinoma, cell line, adrenal gland .e 490 to 1291 11 to 800       790/940
(84 %)
32 diff
(96.6 %id)
BG327981 Kidney, renal cell adenocarcinoma .e 490 to 1167 1 to 675       675/676
(99 %)
10 diff
(98.6 %id)
BG104278 melanotic melanoma, skin .e 491 to 1260 1 to 766       766/843
(90 %)
14 diff
(98.4 %id)
EL955482 eyeball .e 510 to 629 28 to 147       120/147
(81 %)
6 diff
(96.0 %id)
BE276219 melanotic melanoma, skin .e 511 to 1127 1 to 617       617/618
(99 %)
1 diff
(99.9 %id)
C17978 placenta .e 513 to 738 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BE254412 eye, retinoblastoma .e 514 to 1217 1 to 705       705/706
(99 %)
13 diff
(98.2 %id)
DR762359 embryonic stem .e 523 to 1255 1 to 733       733/733
(100 %)
1 diff
(99.9 %id)
CX755130 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 524 to 1004 8 to 488     Submitted on the opposite strand 481/751
(64 %)
10 diff
(98.7 %id)
CX869780 embryonic stem .e 537 to 1233 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
BG248731 adenocarcinoma cell line, colon .e 540 to 1301 1 to 748       748/896
(83 %)
20 diff
(97.8 %id)
DB496189.
matches multiple genes
hypothalamus .e 547 to 1010 1 to 464     also hits gene speezeeby 464/464
(100 %)
0 diff
(100 %id)
DB498495.
matches multiple genes
hypothalamus .e 547 to 1057 1 to 511     also hits gene speezeeby 511/511
(100 %)
0 diff
(100 %id)
TI_154187780   .e 548 to 1388 96 to 928 R202D F203S R204G Q205S Q206S ...     833/1082
(76 %)
22 diff
(98.0 %id)
TI_154188423   .e 548 to 1044 96 to 591       496/1016
(48 %)
19 diff
(98.2 %id)
BX480730   .e 551 to 1223 1 to 673       673/673
(100 %)
4 diff
(99.5 %id)
BF969681 adrenal cortex carcinoma, cell line, adrenal gland .e 556 to 1292 1 to 733       733/736
(99 %)
6 diff
(99.2 %id)
BU079080 Pancreas, Purified pancreatic islet .e 563 to 1038 1 to 475       475/475
(100 %)
4 diff
(99.2 %id)
AU135789 placenta .e 567 to 1267 2 to 708   capped   707/768
(92 %)
18 diff
(97.7 %id)
CX762209 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 570 to 1242 1 to 668       668/847
(78 %)
12 diff
(98.6 %id)
BQ949338 large cell carcinoma, lung .e 585 to 1532 1 to 947 exact     947/951
(99 %)
11 diff
(98.9 %id)
BU193266 eye, retinoblastoma .e 586 to 1378 1 to 801 R223K E225G P227G P228L R229P ...     801/872
(91 %)
16 diff
(98.2 %id)
DR159260 human embryonic stem cells differentiated toan early endodermal cell type .e 595 to 1332 1 to 738       738/738
(100 %)
3 diff
(99.6 %id)
BU194159 melanotic melanoma, skin .e 596 to 1380 1 to 791 R222L R223K A224G E225R G226R ...     791/892
(88 %)
15 diff
(98.4 %id)
BQ420732 embryonal carcinoma, cell line, testis .e 603 to 1365 1 to 766 P235T E236*     766/922
(83 %)
5 diff
(99.5 %id)
BT019393   .e 606 to 1350 1 to 745       745/747
(99 %)
2 diff
(99.8 %id)
BT019432   .e 606 to 1350 1 to 745       745/747
(99 %)
2 diff
(99.8 %id)
CR541700   .e 606 to 1349 1 to 744       744/744
(100 %)
0 diff
(100 %id)
BE885072 leiomyosarcoma, uterus .e 622 to 1336 1 to 712       712/874
(81 %)
22 diff
(97.5 %id)
BM792202 Ascites, stomach .e 622 to 1255 1 to 634       634/634
(100 %)
0 diff
(100 %id)
AI929809 brain, frontal lobe .e 625 to 851 227 to 1   fully sequenced,   227/227
(100 %)
0 diff
(100 %id)
BM697588 eye, fetal eyes .e 633 to 1130 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
BE790105 large cell carcinoma, lung .e 649 to 1374 1 to 721       721/768
(93 %)
12 diff
(98.5 %id)
BY994113   .e 656 to 1355 11 to 710       702/710
(98 %)
8 diff
(98.9 %id)
BE513515 Burkitt lymphoma, lymph .e 662 to 1334 1 to 665       665/707
(94 %)
18 diff
(97.5 %id)
BE561167 Burkitt lymphoma, lymph .e 662 to 1535 1 to 870       870/883
(98 %)
38 diff
(95.7 %id)
BQ054821 lymph, lymphoma, cell line .e 685 to 1490 1 to 812       812/1065
(76 %)
35 diff
(96.8 %id)
BQ650785 hepatocellular carcinoma, cell line, Liver .e 685 to 1543 1 to 866       866/866
(100 %)
9 diff
(99.0 %id)
BQ642007 lymph, lymphoma, cell line .e 685 to 1543 1 to 876       876/889
(98 %)
20 diff
(97.8 %id)
BQ643314 lymph, lymphoma, cell line .e 685 to 1562 1 to 890       890/904
(98 %)
24 diff
(97.4 %id)
CX865969 embryonic stem .e 685 to 1310 1 to 626       626/626
(100 %)
0 diff
(100 %id)
CX866447 embryonic stem .e 699 to 1358 1 to 660       660/660
(100 %)
1 diff
(99.9 %id)
BU554056 ovary, teratocarcinoma, cell line .e 715 to 1609 1 to 901       901/905
(99 %)
14 diff
(98.5 %id)
BG336920 leiomyosarcoma cell line, uterus .e 719 to 1499 1 to 765       765/959
(79 %)
26 diff
(97.3 %id)
BE614709 adenocarcinoma, Pancreas .e 720 to 1595 1 to 871       871/1046
(83 %)
39 diff
(96.3 %id)
AA316108 colon .e 729 to 1259 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BQ071648 brain, neuroblastoma, cell line .e 730 to 1381 1 to 655   AAA   655/1182
(55 %)
13 diff
(99.0 %id)
TI_57146426   .e 733 to 1645 27 to 932       906/932
(97 %)
16 diff
(98.3 %id)
BI760922 pooled colon, kidney, stomach .e 742 to 1645 1 to 897       897/897
(100 %)
11 diff
(98.8 %id)
BU857364 adenocarcinoma, cell line, breast .e 753 to 1507 1 to 764       764/967
(79 %)
13 diff
(98.7 %id)
TI_57188823   .e 780 to 1621 49 to 917       870/873
(99 %)
55 diff
(93.7 %id)
TI_57247503   .e 813 to 1750 57 to 989       938/990
(94 %)
34 diff
(96.6 %id)
BF976283 B-cells, primary B-cells from tonsils (cell line) .e 816 to 1593 1 to 767       767/950
(80 %)
23 diff
(97.6 %id)
BI912417 leukocyte .e 824 to 1750 1 to 923       923/924
(99 %)
28 diff
(97.0 %id)
CN290463 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 833 to 1600 1 to 768       768/768
(100 %)
0 diff
(100 %id)
BQ068554 brain, neuroblastoma, cell line .e 836 to 1778 1 to 958       958/993
(96 %)
28 diff
(97.2 %id)
BE542914 cervix .e 863 to 1586 1 to 720       720/866
(83 %)
20 diff
(97.7 %id)
BU180055 melanotic melanoma, cell line, skin .e 863 to 1578 28 to 747       720/941
(76 %)
23 diff
(97.6 %id)
BE907269 epithelioid carcinoma, Pancreas .e 869 to 1605 1 to 726       726/767
(94 %)
9 diff
(98.9 %id)
AL550596 placenta, Placenta Cot 25-normalized .e 873 to 1868 1011 to 20       992/1011
(98 %)
21 diff
(98.0 %id)
BG679221 skin, squamous cell carcinoma .e 875 to 1639 1 to 764       764/764
(100 %)
3 diff
(99.7 %id)
BX365424 Placenta Cot 25-normalized .e 889 to 1863 976 to 1       976/976
(100 %)
27 diff
(97.3 %id)
BX365181 Placenta Cot 25-normalized .e 892 to 1892 1001 to 1       1001/1001
(100 %)
15 diff
(98.6 %id)
BU170054 large cell carcinoma, lung .e 897 to 1795 1 to 906       906/906
(100 %)
14 diff
(98.5 %id)
BM722568 eye, fetal eye .e 901 to 1491 1 to 593       593/593
(100 %)
5 diff
(99.2 %id)
BQ671407 epidermoid carcinoma, cell line, salivary gland .e 913 to 1684 1 to 778       778/897
(86 %)
19 diff
(97.9 %id)
BU956122 adenocarcinoma, cell line, breast .e 913 to 1684 1 to 780       780/895
(87 %)
19 diff
(97.9 %id)
AL577431 placenta, Placenta Cot 25-normalized .e 917 to 1829 910 to 1       910/944
(96 %)
36 diff
(96.2 %id)
BU856647 adenocarcinoma, cell line, breast .e 944 to 1739 1 to 807       807/963
(83 %)
31 diff
(96.8 %id)
BF970728 adrenal cortex carcinoma, cell line, adrenal gland .e 957 to 1711 1 to 752       752/752
(100 %)
3 diff
(99.7 %id)
BM558481 duodenal adenocarcinoma, cell line, small intestine .e 958 to 1938 1 to 990       990/995
(99 %)
22 diff
(97.8 %id)
BQ676790 melanotic melanoma, cell line, skin .e 964 to 1784 1 to 825       825/914
(90 %)
16 diff
(98.3 %id)
BM549517 astrocytoma grade IV, cell line, brain .e 967 to 1931 27 to 998   AAA   972/998
(97 %)
39 diff
(96.1 %id)
AL552188 placenta, Placenta Cot 25-normalized .e 974 to 1899 920 to 1   fully sequenced,   920/920
(100 %)
5 diff
(99.5 %id)
BM553473 amelanotic melanoma, cell line, skin .e 980 to 1742 1 to 767       767/1059
(72 %)
20 diff
(98.2 %id)
BG676309 skin, squamous cell carcinoma .e 981 to 1863 1 to 878       878/1073
(81 %)
13 diff
(98.8 %id)
BQ679355 melanotic melanoma, cell line, skin .e 982 to 1921 1 to 940       940/940
(100 %)
6 diff
(99.4 %id)
TI_149291344   .e 997 to 1921 995 to 79   AAA   917/941
(97 %)
23 diff
(97.6 %id)
CN290461 embryonic stem cells, DMSO-treated H9 cellline .e 998 to 1676 1 to 679       679/679
(100 %)
3 diff
(99.6 %id)
TI_227714506   .e 999 to 1921 1007 to 93   AAA   915/973
(94 %)
26 diff
(97.4 %id)
TI_227715661   .e 1000 to 1921 1042 to 121   AAA   922/1009
(91 %)
38 diff
(96.3 %id)
TI_159679904   .e 1001 to 1908 906 to 1       906/989
(91 %)
32 diff
(96.8 %id)
BF737683 bladder_tumor .e 1004 to 1467 467 to 4     Submitted on the opposite strand 464/483
(96 %)
1 diff
(99.8 %id)
AL578342 placenta .e 1004 to 1888 888 to 1       888/888
(100 %)
41 diff
(95.4 %id)
TI_149294655   .e 1004 to 1928 1003 to 81   AAA   923/1015
(90 %)
21 diff
(98.0 %id)
TI_159712971   .e 1004 to 1928 1023 to 106   AAA   918/1042
(88 %)
9 diff
(99.2 %id)
TI_227714571   .e 1004 to 1931 1021 to 97   AAA   925/1006
(91 %)
26 diff
(97.5 %id)
TI_227714727   .e 1004 to 1928 1024 to 107   AAA   918/993
(92 %)
18 diff
(98.2 %id)
CR610416 fetal brain .e 1007 to 1918 1 to 912       912/912
(100 %)
0 diff
(100 %id)
BX441121 brain, fetal brain .e 1007 to 1927 1 to 917   fully sequenced,   917/917
(100 %)
5 diff
(99.5 %id)
BF969497 adrenal cortex carcinoma, cell line, adrenal gland .e 1007 to 1760 1 to 744       744/833
(89 %)
14 diff
(98.4 %id)
BF769737 epid_tumor .e 1022 to 1279 1 to 258       258/258
(100 %)
0 diff
(100 %id)
BU859952 adenocarcinoma, cell line, breast .e 1031 to 1933 1 to 909       909/910
(99 %)
12 diff
(98.7 %id)
CF553074 Pooled muscle (cardiac and skeletal) .e 1035 to 1914 1 to 899       899/910
(98 %)
38 diff
(95.9 %id)
TI_154053141   .e 1053 to 1921 952 to 93   AAA   860/959
(89 %)
12 diff
(98.8 %id)
CN290473 embryonic stem cells, DMSO-treated H9 cellline .e 1054 to 1692 1 to 639       639/639
(100 %)
0 diff
(100 %id)
AV726569 hypothalamus .e 1057 to 1360 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AL562853 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .e 1070 to 1876 808 to 1   fully sequenced,   808/808
(100 %)
2 diff
(99.8 %id)
AL569951 placenta, Placenta Cot 25-normalized .e 1070 to 1899 830 to 1   fully sequenced,   830/830
(100 %)
6 diff
(99.3 %id)
AL574886 placenta, Placenta Cot 25-normalized .e 1070 to 1898 828 to 1   fully sequenced,   828/828
(100 %)
5 diff
(99.4 %id)
AL573440 placenta, Placenta Cot 25-normalized .e 1070 to 1891 824 to 1   fully sequenced,   824/824
(100 %)
1 diff
(99.9 %id)
AL575758 placenta, Placenta Cot 25-normalized .e 1070 to 1894 827 to 1   fully sequenced,   827/827
(100 %)
5 diff
(99.4 %id)
AL553028 placenta, Placenta Cot 25-normalized .e 1070 to 1888 819 to 1   fully sequenced,   819/819
(100 %)
12 diff
(98.6 %id)
AL580643 T cells from T cell leukemia .e 1070 to 1879 820 to 10   fully sequenced,   811/820
(98 %)
3 diff
(99.7 %id)
AL578553 placenta .e 1070 to 1885 818 to 1   fully sequenced,   818/818
(100 %)
3 diff
(99.7 %id)
BG743978 blood, natural killer cells, cell line .e 1070 to 1921 1 to 850   fully sequenced,   850/850
(100 %)
19 diff
(97.8 %id)
BM887733 eye .e 1084 to 1557 1 to 474       474/474
(100 %)
0 diff
(100 %id)
BE614459 leiomyosarcoma, uterus .e 1085 to 1888 794 to 1       794/965
(82 %)
23 diff
(97.7 %id)
BG987937 head_neck .e 1091 to 1194 5 to 108       104/108
(96 %)
9 diff
(91.7 %id)
BG288863 bladder, transitional cell papilloma, cell line .e 1092 to 1884 1 to 779       779/839
(92 %)
28 diff
(96.7 %id)
TI_149290157   .e 1100 to 1921 905 to 90   AAA   816/817
(99 %)
16 diff
(98.1 %id)
BF690169 melanotic melanoma, high MDR (cell line), skin .e 1103 to 1868 769 to 1   fully sequenced,   769/769
(100 %)
36 diff
(95.4 %id)
AL565069 adult brain, brain .e 1104 to 1884 783 to 4   fully sequenced,   780/783
(99 %)
1 diff
(99.9 %id)
AL546129 placenta, Placenta Cot 25-normalized .e 1105 to 1897 791 to 1   fully sequenced,   791/791
(100 %)
7 diff
(99.2 %id)
BQ639705 eye, retina .e 1107 to 1713 1 to 607       607/607
(100 %)
0 diff
(100 %id)
CR612490 placenta .e 1109 to 1939 1 to 831   tiling clone,   831/831
(100 %)
0 diff
(100 %id)
AL540956 placenta .e 1109 to 1921 1 to 813   fully sequenced, AAA   813/813
(100 %)
1 diff
(99.9 %id)
BF943538 nervous_normal .e 1116 to 1656 556 to 14     Submitted on the opposite strand 543/559
(97 %)
9 diff
(98.4 %id)
CN290466 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 1118 to 1654 1 to 537       537/537
(100 %)
0 diff
(100 %id)
AL557550 T cells (Jurkat cell line), T cells from T cell leukemia .e 1123 to 1904 786 to 1       786/786
(100 %)
12 diff
(98.5 %id)
BF771912 epid_tumor .e 1125 to 1413 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AL540955 placenta .e 1134 to 1892 758 to 1   fully sequenced,   758/758
(100 %)
5 diff
(99.4 %id)
AL532904 adult brain, brain .e 1134 to 1885 751 to 1   fully sequenced,   751/751
(100 %)
5 diff
(99.4 %id)
TI_154130199   .e 1134 to 1930 903 to 112   AAA   772/966
(79 %)
40 diff
(95.9 %id)
BE782614 eye, retinoblastoma .e 1136 to 1932 1 to 790       790/825
(95 %)
27 diff
(96.8 %id)
EB386917 eye, optic nerve .e 1138 to 1916 1 to 779       779/779
(100 %)
0 diff
(100 %id)
BG818034 anaplastic oligodendroglioma with 1p/19qloss, brain .e 1139 to 1862 1 to 724       724/725
(99 %)
3 diff
(99.6 %id)
BM788154 Ascites, stomach .e 1148 to 1785 1 to 638       638/638
(100 %)
0 diff
(100 %id)
CB850573 lung, Primary Lung Epithelial Cells .e 1150 to 1681 7 to 538     Submitted on the opposite strand 532/538
(98 %)
5 diff
(99.1 %id)
CB853079 Human Lung Epithelial cells, lung .e 1150 to 1681 7 to 538     Submitted on the opposite strand 532/539
(98 %)
5 diff
(99.1 %id)
CB162835 Liver .e 1151 to 1728 1 to 578       578/578
(100 %)
0 diff
(100 %id)
AW609043 pnet .e 1165 to 1557 403 to 5       399/417
(95 %)
15 diff
(96.5 %id)
BX365630   .e 1165 to 1883 719 to 1       719/719
(100 %)
4 diff
(99.5 %id)
TI_149280957   .e 1165 to 1681 124 to 640     Submitted on the opposite strand 513/848
(60 %)
15 diff
(98.3 %id)
TI_149304327   .e 1165 to 1681 69 to 585     Submitted on the opposite strand 517/1016
(50 %)
5 diff
(99.6 %id)
TI_159722331   .e 1165 to 1681 63 to 579     Submitted on the opposite strand 517/1107
(46 %)
5 diff
(99.6 %id)
BF344269 brain, glioblastoma with EGFR amplification .e 1167 to 1909 1 to 743       743/781
(95 %)
15 diff
(98.1 %id)
CB854252 lung, Primary Lung Epithelial Cells .e 1167 to 1681 1 to 515     Submitted on the opposite strand 515/515
(100 %)
9 diff
(98.3 %id)
BM693920 eye, RPE and Choroid .e 1167 to 1455 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BM704779 eye, RPE and Choroid .e 1167 to 1720 1 to 554       554/554
(100 %)
0 diff
(100 %id)
AL515245 neuroblastoma, placenta .e 1168 to 1929 762 to 1   fully sequenced,   762/762
(100 %)
9 diff
(98.9 %id)
CB851959 Human Lung Epithelial cells, lung .e 1182 to 1928 757 to 12   AAA   746/746
(100 %)
1 diff
(99.9 %id)
BI020530 marrow .e 1186 to 1472 290 to 5       286/292
(97 %)
3 diff
(99.0 %id)
BF772171 epid_tumor .e 1187 to 1556 377 to 1     Submitted on the opposite strand 377/377
(100 %)
28 diff
(92.6 %id)
CA312845 Human Lung Epithelial cells, lung .e 1202 to 1921 739 to 19   AAA   721/721
(100 %)
1 diff
(99.9 %id)
TI_149291132   .e 1213 to 1928 794 to 81   AAA   714/714
(100 %)
12 diff
(98.4 %id)
BF927803 nervous_tumor .e 1220 to 1547 358 to 31     Submitted on the opposite strand 328/358
(91 %)
0 diff
(100 %id)
TI_149272877   .e 1220 to 1928 821 to 116   AAA   706/906
(77 %)
15 diff
(98.4 %id)
TI_149287293   .e 1221 to 1921 785 to 85   AAA   701/702
(99 %)
11 diff
(98.5 %id)
BF220273 lung, small cell carcinoma .e 1223 to 1885 666 to 1       666/690
(96 %)
11 diff
(98.5 %id)
TI_154105020   .e 1223 to 1928 786 to 84   AAA   703/704
(99 %)
7 diff
(99.1 %id)
TI_149292644   .e 1228 to 1928 782 to 89   AAA   694/706
(98 %)
10 diff
(98.6 %id)
BM743171 stomach .e 1243 to 1864 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BQ772603 Chondrosarcoma Cell line .e 1245 to 1921 695 to 19   AAA   677/677
(100 %)
0 diff
(100 %id)
TI_154019676   .e 1246 to 1928 783 to 102   AAA   682/682
(100 %)
4 diff
(99.5 %id)
AW806737 stomach .e 1251 to 1411 163 to 3       161/163
(98 %)
4 diff
(97.6 %id)
BG744657 blood, natural killer cells, cell line .e 1256 to 1871 617 to 1   fully sequenced,   617/617
(100 %)
9 diff
(98.6 %id)
TI_149290982   .e 1258 to 1933 780 to 107       674/784
(85 %)
4 diff
(99.5 %id)
AW893535 nervous_normal .e 1267 to 1506 241 to 1       241/241
(100 %)
13 diff
(94.7 %id)
CA415450 Chondrosarcoma Grade II, Left Pelvis .e 1274 to 1921 666 to 19   AAA   648/652
(99 %)
0 diff
(100 %id)
TI_43961331   .e 1276 to 1852 588 to 2       587/761
(77 %)
9 diff
(98.9 %id)
BX373258 Placenta Cot 25-normalized .e 1284 to 1918 637 to 1   fully sequenced,   637/637
(100 %)
14 diff
(97.9 %id)
CD365359 Alveolar Macrophage, lung .e 1298 to 1928 642 to 12   AAA   631/631
(100 %)
0 diff
(100 %id)
FN063770 breast carcinoma .e 1302 to 1380 1 to 79       79/84
(94 %)
2 diff
(97.7 %id)
BQ722539 sympathetic trunk .e 1310 to 1929 1 to 620       620/945
(65 %)
5 diff
(99.5 %id)
FN155032 breast carcinoma .e 1313 to 1425 115 to 1     Submitted on the opposite strand 115/115
(100 %)
2 diff
(98.3 %id)
CX867817 embryonic stem .e 1318 to 1921 632 to 28   AAA   605/605
(100 %)
10 diff
(98.4 %id)
BM973975 lung .e 1325 to 1921 615 to 19   AAA   597/597
(100 %)
0 diff
(100 %id)
CA446312 Chondrosarcoma, Left Pubic Bone .e 1326 to 1928 614 to 12   AAA   603/603
(100 %)
0 diff
(100 %id)
CD365099 Alveolar Macrophage, lung .e 1326 to 1921 614 to 19   AAA   596/596
(100 %)
0 diff
(100 %id)
BM913557 amelanotic melanoma, cell line, skin .e 1342 to 1931 650 to 58   AAA Submitted on the opposite strand 593/610
(97 %)
11 diff
(98.2 %id)
BQ771948 Chondrosarcoma Grade II, Left Pelvis .e 1353 to 1928 594 to 19   AAA   576/576
(100 %)
0 diff
(100 %id)
CA423633 cell lines, Chondrosarcoma .e 1354 to 1928 593 to 19   AAA   575/575
(100 %)
0 diff
(100 %id)
BU683299 lung .e 1355 to 1928 585 to 12   AAA   574/574
(100 %)
0 diff
(100 %id)
TI_227715733   .e 1367 to 1928 642 to 81   AAA   562/997
(56 %)
28 diff
(97.2 %id)
BM974716 lung .e 1378 to 1928 561 to 12   AAA   550/550
(100 %)
0 diff
(100 %id)
BU730342 eye, RPE and Choroid .e 1387 to 1928 553 to 12   AAA   542/542
(100 %)
0 diff
(100 %id)
TI_57186762   .e 1395 to 1933 92 to 632       541/806
(67 %)
10 diff
(98.8 %id)
CB053849 leiomyosarcoma, soft tissue .e 1397 to 1925 10 to 539   fully sequenced,   530/539
(98 %)
6 diff
(98.9 %id)
BF594202 brain, glioblastoma (pooled) .e 1416 to 1925 510 to 1       510/510
(100 %)
0 diff
(100 %id)
CB053848 leiomyosarcoma, soft tissue .e 1436 to 1921 519 to 33   fully sequenced, AAA   487/487
(100 %)
0 diff
(100 %id)
AI148736 placenta .e 1440 to 1929 490 to 1       490/490
(100 %)
0 diff
(100 %id)
BE857208 brain, glioblastoma (pooled) .e 1444 to 1924 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BG611853 adenocarcinoma, Prostate .e 1486 to 1834 1 to 349   AAA   349/349
(100 %)
0 diff
(100 %id)
BM679219 eye, fetal eye .e 1494 to 1921 446 to 19   AAA   428/428
(100 %)
1 diff
(99.8 %id)
BU078800 Pancreas, Purified pancreatic islet .e 1495 to 1932 437 to 1       437/437
(100 %)
6 diff
(98.7 %id)
AA204992   .e 1538 to 1927 392 to 3       390/392
(99 %)
0 diff
(100 %id)
BE301669 cervical carcinoma cell line, cervix .e 1548 to 1923 376 to 1       376/376
(100 %)
0 diff
(100 %id)
F26744 pectoral muscle (after mastectomy) .e 1607 to 1797 1 to 191       191/191
(100 %)
0 diff
(100 %id)
AU156286 placenta .e 1609 to 1938 330 to 1       330/333
(99 %)
5 diff
(98.5 %id)
F31545 pectoral muscle (after mastectomy) .e 1618 to 1726 1 to 109       109/109
(100 %)
0 diff
(100 %id)
BX351879 Placenta Cot 25-normalized .e 1620 to 1899 278 to 1       278/281
(98 %)
8 diff
(97.2 %id)
Z39332 brain, total brain .e 1628 to 1921 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AA114253 brain, neuroepithelial cells .e 1647 to 1927 282 to 3       280/282
(99 %)
0 diff
(100 %id)
BU735772 eye, fetal eyes .e 1677 to 1928 263 to 12   AAA   252/252
(100 %)
0 diff
(100 %id)
BX455099 brain, fetal brain .e 1699 to 1918 219 to 1   fully sequenced,   219/219
(100 %)
1 diff
(99.6 %id)
AA476414   .e 1769 to 1925 157 to 1       157/157
(100 %)
0 diff
(100 %id)
BI793166 Islets of Langerhans, Pancreas .e 1841 to 1931 1 to 91   AAA   91/91
(100 %)
0 diff
(100 %id)
BE796540 lung, small cell carcinoma .f 1 to 851 1 to 846   tiling clone,   844/846
(99 %)
14 diff
(98.4 %id)
BI916037 brain .g 1 to 754 1 to 756 G34C Y96* tiling clone,   756/756
(100 %)
9 diff
(98.9 %id)
TI_57244336   .g 1 to 754 31 to 786 G34C Y96*     756/786
(96 %)
14 diff
(98.3 %id)
BG709513 brain, hypothalamus .g 390 to 1157 1 to 766   tiling clone,   766/863
(88 %)
25 diff
(97.2 %id)
BF737168 bladder_tumor .g 421 to 963 19 to 559   tiling clone,   541/560
(96 %)
7 diff
(98.8 %id)
DT218622 brain .g 534 to 1119 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
BQ306682 breast .g 865 to 1387 1 to 529       529/529
(100 %)
16 diff
(97.0 %id)
BQ306673 breast .g 872 to 1401 1 to 529   tiling clone,   529/529
(100 %)
10 diff
(98.2 %id)
BQ306689 breast .g 872 to 1429 1 to 556       556/560
(99 %)
10 diff
(98.3 %id)
BQ308152 breast .g 872 to 1435 1 to 563   tiling clone,   563/563
(100 %)
4 diff
(99.3 %id)
CR595195 placenta Gene MLF2, variant not shown         Suspected internal deletion, this clone was ignored    
BQ056680 lymph, lymphoma, cell line Gene MLF2, variant not shown         Suspected internal deletion, this clone was ignored    
U57342   Gene MLF2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI